Infection News

Dicerna dosed the first patient in a phase 1 clinical trial for DCR-HBVS, an investigational GalXCTM-based therapy for the treatment of chronic hepatitis B, according to a press release.

RedHill Biopharma announced that it has submitted a new drug application to the FDA for Talicia to treat H. pylori infection.

Patients with inflammatory bowel disease have higher hospitalization rates for herpes zoster virus compared with other people without IBD, according to study results.

Prophylactic oral vancomycin does not consistently reduce the risk for Clostridioides difficile infection, or CDI, relapse in patients receiving systemic antibiotics during hospitalization, researchers found.

A recent study published in mBio suggested that treatment with albendazole for hookworms and roundworms did not have a harmful effect on patients’ gut microbiome composition.

VIENNA — In this exclusive video from the International Liver Congress 2019, Philippa Easterbrook, MD, senior scientist of the Global Hepatitis Program within the HIV Department at the WHO headquarters in Geneva, Switzerland, discusses a symposium focused on sharing “good practices and lessons learned” in the global viral hepatitis response.

Nearly one-quarter of children with autism spectrum disorder have pica — an eating disorder involving the eating of nonfood items — according to research presented at the CDC’s Epidemic Intelligence Service Conference.

Patients with recurrent Clostridioides difficile infection on average avoided 17 days of hospitalization in the first year after being treated with fecal microbiota transplantation, according to real-world data.

ATLANTA — Contaminated asparagus was the likely source of a large outbreak of shigellosis at a wedding party in Oregon that sickened 112 people, according to findings presented at the CDC’s Epidemic Intelligence Service, or EIS, conference.

The FDA approved Mavyret to treat all six genotypes of hepatitis C in pediatric patients aged 12 years to 17 years, according to a press release from the organization.